Zong, Y.; Qiu, S.; Yang, M.; Zhang, J.; Zou, Y.; Jing, Y.; Ohno-Matsui, K.; Kamoi, K.
Teprotumumab for Thyroid Eye Disease: Mechanism, Clinical Efficacy, and Current Challenges. Antibodies 2025, 14, 55.
https://doi.org/10.3390/antib14030055
AMA Style
Zong Y, Qiu S, Yang M, Zhang J, Zou Y, Jing Y, Ohno-Matsui K, Kamoi K.
Teprotumumab for Thyroid Eye Disease: Mechanism, Clinical Efficacy, and Current Challenges. Antibodies. 2025; 14(3):55.
https://doi.org/10.3390/antib14030055
Chicago/Turabian Style
Zong, Yuan, Shuang Qiu, Mingming Yang, Jing Zhang, Yaru Zou, Yuxin Jing, Kyoko Ohno-Matsui, and Koju Kamoi.
2025. "Teprotumumab for Thyroid Eye Disease: Mechanism, Clinical Efficacy, and Current Challenges" Antibodies 14, no. 3: 55.
https://doi.org/10.3390/antib14030055
APA Style
Zong, Y., Qiu, S., Yang, M., Zhang, J., Zou, Y., Jing, Y., Ohno-Matsui, K., & Kamoi, K.
(2025). Teprotumumab for Thyroid Eye Disease: Mechanism, Clinical Efficacy, and Current Challenges. Antibodies, 14(3), 55.
https://doi.org/10.3390/antib14030055
